Status:
COMPLETED
Evaluation of Musculoskeletal System Symptoms and Biochemical Parameters in COVID-19
Lead Sponsor:
Abant Izzet Baysal University
Conditions:
Covid19
Eligibility:
All Genders
18-70 years
Brief Summary
The neutrophil-lymphocyte ratio (NLR) used to demonstrate inflammatory status in recent years can be calculated by dividing the absolute neutrophil count by the absolute lymphocyte count at routine bl...
Detailed Description
Dysregulation in immune responses has been reported in association with hyperinflammation in COVID-19 patients, NLR has been linked to the severity of the patient's clinical status, and an increase in...
Eligibility Criteria
Inclusion
- Aged 18-70
- Diagnosed with COVID-19
Exclusion
- Patients with suspected SARS-CoV-2 infection, with two negative RT-PCR tests, hospitalized in the intensive care unit during inclusion in the study
- Musculoskeletal pains in the previous three months, with diseases capable of causing myalgia prior to diagnosis (such as fibromyalgia and inflammatory muscle disease)
- Cognitive disorders capable of preventing history-taking and physical examination such as mental disability and dementia,
- previous history of headache (migraine, tension type headache)
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04780555
Start Date
March 1 2021
End Date
August 1 2021
Last Update
August 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Elif Yakşi
Merkez, Bolu, Turkey (Türkiye), 14030